CrizotinibDevelopment of resistance during treatment for non-small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1666卷 / 1期

关键词：

D O I：

10.1007/s40278-017-34933-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[1] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1633 (1) : 231 - 231
[2] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1754 (1) : 120 - 120
[3] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1733 (1) : 121 - 121
[4] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2016, 1616 (1) : 15 - 15
[5] Brigatinib/crizotinibDevelopment of resistance to brigatinib and crizotinibin in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1780 (1) : 80 - 80
[6] Alectinib/crizotinibDevelopment of drug resistance in ALK-positive non-small cell lung cancer: case report
Reactions Weekly, 2020, 1829 (1) : 23 - 23
[7] CrizotinibDevelopment of resistance to crizotinib during treatment of lung cancer: case report
Reactions Weekly, 2018, 1728 (1) : 114 - 114
[8] CrizotinibDevelopment of resistance in non-small cell lung cancer, and various toxicities: 2 case reports
Reactions Weekly, 2021, 1880 (1) : 139 - 139
[9] Ceritinib/crizotinibDevelopment of resistance in EML4-ALK-positive non-small cell lung cancer: case report
Reactions Weekly, 2017, 1635 (1) : 75 - 75
[10] AlectinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1682 (1) : 24 - 24

← 1 2 3 4 5 →